Skip to main content
2024 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Certified Pharmacy Executive Leader
Digital Health & Informatics
Digital Health & Informatics
Diversity, Equity and Inclusion
Diversity, Equity and Inclusion
Health & Wellness
Health & Wellness
Opioids & Pain Management
Opioids & Pain Management
Sterile Compounding
Sterile Compounding
Back
Handout

Educational Sessions

Assesstivus for the Rest of US [IDS folks]: Establishing a Network-Wide Assessment of Risk Process for Investigational Drugs

Wednesday, December 11, 2024
3:30 PM – 5:00 PM  
Location: MCCNO, Room 272, Level 2
CE Credits: 1.50 contact hours
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists
Activity #: 0204-0000-24-338-L05-P
Activity #: 0204-0000-24-338-L05-T
Activity Type: Application-based
Target Audience: Pharmacist, Pharmacy Technician

Learning Objectives:

  • Identify the regulatory group(s) that are responsible for establishing toxicological characteristics that warrant a hazardous designation.
  • Describe the six toxicological characteristics that warrant a hazardous designation.
  • Apply key information from an investigator brochure to predetermined levels outlined in an assessment of risk tool.